AH Capital Management Portfolio holdings
AH Capital Management is the company behind Andreessen Horowitz, also known as a16z, a venture capital firm. It was founded in 2009 by Marc Andreessen, co-creator of the Mosaic web browser and co-founder of Netscape, and Ben Horowitz, who co-founded the software company Opsware. The firm backs early-stage startups and established growth companies, across healthcare, consumer, crypto, gaming, fintech, education and enterprise software. In 2023 it launched its American Dynamism fund, which backs companies in space, defense, manufacturing and robotics.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$12.7B |
| 2 |
Roblox
RBLX
|
+$13.7M |
| 3 |
Kailera Therapeutics
KLRA
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Figma
FIG
|
+$202M |
| 2 |
Nautilus Biotechnolgy
NAUT
|
+$22.7M |
| 3 |
Omada Health Inc
OMDA
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 89.97% |
| 2 | Technology | 5.85% |
| 3 | Healthcare | 3.21% |
| 4 | Communication Services | 0.95% |
| 5 | Financials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
SpaceX
SPCX
$1.85T
| $12.8B | 89.97% |
+74,855,020
| New | +$12.7B |
2026 Q2
0 quarters
|
|
2
Navan Inc
NAVN
$6.61B
| $645M | 4.54% |
28,218,676
| – | – |
2025 Q4
2 quarters
|
|
3
Revolution Medicines
RVMD
$40.3B
| $173M | 1.21% |
921,099
| – | – |
2023 Q4
10 quarters
|
|
4
Meta Platforms (Facebook)
META
$1.58T
| $120M | 0.84% |
212,531
| – | – |
2025 Q3
3 quarters
|
|
|
5
Figma
FIG
$11.8B
| $108M | 0.76% |
5,983,308
-10,028,070
| -63% | -$202M |
2025 Q3
3 quarters
|
|
6
BioAge Labs
BIOA
$266M
| $79.2M | 0.56% |
3,233,170
| – | – |
2024 Q3
7 quarters
|
|
7
Block Inc
XYZ
$46.3B
| $77.3M | 0.54% |
1,016,697
| – | – |
2023 Q4
10 quarters
|
|
8
Erasca
ERAS
$4.91B
| $52.4M | 0.37% |
2,862,500
| – | – |
2023 Q4
10 quarters
|
|
9
Maze Therapeutics
MAZE
$1.69B
| $50.8M | 0.36% |
1,702,225
| – | – |
2025 Q1
5 quarters
|
|
|
DMRA
10
Damora Therapeutics
DMRA
$1.33B
| $32.2M | 0.23% |
1,236,157
| – | – |
2026 Q1
1 quarter
|
|
|
11
Omada Health Inc
OMDA
$1.09B
| $25.3M | 0.18% |
1,153,639
-1,153,645
| -50% | -$18.4M |
2025 Q2
4 quarters
|
|
|
12
Nautilus Biotechnolgy
NAUT
$297M
| $16.9M | 0.12% |
9,063,054
-8,590,863
| -49% | -$22.7M |
2023 Q4
10 quarters
|
|
|
13
Roblox
RBLX
$30.7B
| $14.9M | 0.11% |
+274,570
| New | +$13.7M |
2026 Q2
0 quarters
|
|
14
Aktis Oncology
AKTS
$811M
| $13.4M | 0.09% |
415,000
| – | – |
2026 Q1
1 quarter
|
|
15
CAMP4 Therapeutics
CAMP
$237M
| $9.29M | 0.07% |
2,125,339
| – | – |
2024 Q4
6 quarters
|
|
16
BitGo Holdings
BTGO
$603M
| $3.45M | 0.02% |
666,356
| – | – |
2026 Q1
1 quarter
|
|
|
17
Kailera Therapeutics
KLRA
$1.58B
| $3.08M | 0.02% |
+140,000
| New | +$3.08M |
2026 Q2
0 quarters
|
|
18
Ginkgo Bioworks
DNA
$663M
| $1.08M | 0.01% |
108,568
| – | – |
2024 Q1
9 quarters
|
|
19
IP Strategy Holdings
IPST
$1.6M
| $9.7K | ﹤0.01% |
4,137
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
AH Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, AH Capital Management held 19 positions worth $14.2B, up 1,001% from $1.29B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
AH Capital Management deployed $12.5B of net new capital in Q2 2026, opening 3 new positions. Its largest new stake was SpaceX: 74,855,020 shares worth $12.8B.
By sector, the portfolio is most concentrated in Industrials at 90% of assets, followed by Technology and Healthcare.
On the sell side, the largest reduction was Figma, an estimated $202M trimmed.
- AH Capital Management's largest Q2 2026 buy was SpaceX: 74,855,020 shares worth $12.8B.
- AH Capital Management's biggest Q2 2026 reduction was Figma, cutting an estimated $202M.
- AH Capital Management's ten largest holdings make up 99% of its $14.2B portfolio in Q2 2026.
- AH Capital Management opened 3 new positions and closed 0 in Q2 2026.
- AH Capital Management's portfolio value rose 1,001% quarter-over-quarter to $14.2B.
Based on AH Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.